This article is more than 5 years old. Information may no longer be current.

Case series: Intravitreal voriconazole effective against refractory fungal endophthalmitis

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Intravitreal injection of voriconazole effectively resolved fungal endophthalmitis that was resistant to conventional antifungal agents, a retrospective case series found.

Parveen Sen, MS, of Sankara Nethralaya in Tamil Nadu, India, and colleagues examined the outcomes of one or more intravitreal voriconazole injections in five patients with refractory fungal endophthalmitis.

Endophthalmitis resolved in all cases. Visual acuity remained stable in two patients and improved in three patients, two of whom achieved 20/120 or better vision. Evisceration was avoided in one patient who received maximal antifungal treatment including voriconazole, according to the authors.

The case series is published in the October issue of Retina.